Samuel S Freeman

14PUBLICATIONS
209CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsMolecular targetsEpigenetics (incl. genome methylation and epigenomics)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jan 07, 2026
IL10R Inhibition Induces Neutrophil Tumoricidal Activity.

Danny N Khalil, Ricardo Gomez, Amit Regev

|Oct 21, 2025
Long-term Survival and Molecular Biomarker Evaluation of a Phase II Cetuximab and Nivolumab Clinical Trial in Recurrent/Metastatic Head and Neck Cancer.

Ritu Chaudhary, Graydon Moorhead, Robin Park

|Jul 16, 2025
Ongoing genome doubling shapes evolvability and immunity in ovarian cancer.

Andrew McPherson, Ignacio Vázquez-García, Matthew A Myers

|Nov 27, 2024
Genomic heterogeneity and ploidy identify patients with intrinsic resistance to PD-1 blockade in metastatic melanoma.

Giuseppe Tarantino, Cora A Ricker, Annette Wang

|Mar 30, 2024
FinaleMe: Predicting DNA methylation by the fragmentation patterns of plasma cell-free DNA.

Yaping Liu, Sarah C Reed, Christopher Lo

|Mar 20, 2024
Human lung cancer harbors spatially organized stem-immunity hubs associated with response to immunotherapy.

Jonathan H Chen, Linda T Nieman, Maxwell Spurrell

Pageof 3

Frequent Collaborators

4 joint publications

Nir Hacohen

4 joint publications

Gad Getz

3 joint publications

Genevieve M Boland

3 joint publications

Catherine J Wu